Dr. Mehmet Bilen has contributed to 3 publications.
Safety of Same-day Pegfilgrastim Administration in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel With or Without Carboplatin.
Bilen MA, Cauley DH, Atkinson BJ, Chen H, Kaya DH, Wang X, Vikram R, Tu S, Corn PG, Kim J; Clin Genitourin Cancer. 2016-12-13.
Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials.
Bilen MA, Patel A, Hess KR, Munoz J, Busaidy NL, Wheler JJ, Janku F, Falchook GS, Hong DS, Meric-Bernstam F, Habra MA, Naing A; Cancer Chemother. Pharmacol.. 2016-07-01.
Dr. Mehmet Bilen has contributed to 3 publications.
Safety of Same-day Pegfilgrastim Administration in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel With or Without Carboplatin.
Bilen MA, Cauley DH, Atkinson BJ, Chen H, Kaya DH, Wang X, Vikram R, Tu S, Corn PG, Kim J; Clin Genitourin Cancer. 2016-12-13.
Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials.
Bilen MA, Patel A, Hess KR, Munoz J, Busaidy NL, Wheler JJ, Janku F, Falchook GS, Hong DS, Meric-Bernstam F, Habra MA, Naing A; Cancer Chemother. Pharmacol.. 2016-07-01.